Vapotherm Inc
NYSE:VAPO
Vapotherm Inc
Cash from Financing Activities
Vapotherm Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vapotherm Inc
NYSE:VAPO
|
Cash from Financing Activities
$21m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.5B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-25%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$7.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Vapotherm Inc's Cash from Financing Activities?
Cash from Financing Activities
21m
USD
Based on the financial report for Dec 31, 2023, Vapotherm Inc's Cash from Financing Activities amounts to 21m USD.
What is Vapotherm Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-23%
Over the last year, the Cash from Financing Activities growth was -59%. The average annual Cash from Financing Activities growth rates for Vapotherm Inc have been -40% over the past three years , -23% over the past five years .